Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Stål

Showing results (41-50 of 128) with videos related to

Pageof 13
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|April 12, 2016
Elevated serum ferritin is associated with increased mortality in non-alcoholic fatty liver disease after 16 years of follow-upHannes Hagström, Patrik Nasr, Matteo Bottai, et al.
Hepatology Communications|February 7, 2018
Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up studyHannes Hagström, Patrik Nasr, Mattias Ekstedt, et al.
Hepatology (Baltimore, Md.)|August 16, 2014
Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-upMattias Ekstedt, Hannes Hagström, Patrik Nasr, et al.
European Journal of Gastroenterology & Hepatology|August 16, 2020
A personalized treatment program in persons with type 2 diabetes is associated with a reduction in liver steatosisKarl Björkström, Per Stål, Magnus Holmer, et al.
Scandinavian Journal of Gastroenterology|September 13, 2016
SAF score and mortality in NAFLD after up to 41 years of follow-upHannes Hagström, Patrik Nasr, Mattias Ekstedt, et al.
Scientific Reports|November 28, 2022
Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver diseaseMagnus Holmer, Hannes Hagström, Ping Chen, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|October 28, 2020
Variation in textural parameters of hepatic lesions during contrast medium injectionYi-Hua Zhang, Katharina Brehmer, Anders Svensson, et al.
Hepatology (Baltimore, Md.)|December 17, 2009
Decreased survival of subjects with elevated liver function tests during a 28-year follow-upCecilia Söderberg, Per Stål, Johan Askling, et al.
Frontiers in Pediatrics|June 26, 2020
Epigenetic Marks at the Ribosomal DNA Promoter in Skeletal Muscle Are Negatively Associated With Degree of Impairment in Cerebral PalsyFerdinand von Walden, Rodrigo Fernandez-Gonzalo, Jessica Pingel, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 22, 2022
Skeletal muscle morphology, satellite cells, and oxidative profile in relation to physical function and lifelong endurance training in very old menElisabeth Skoglund, Per Stål, Tommy R Lundberg, et al.
Pageof 13

Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
Liver International : Official Journal of the International Association for the Study of the Liver|April 12, 2016
Elevated serum ferritin is associated with increased mortality in non-alcoholic fatty liver disease after 16 years of follow-upHannes Hagström, Patrik Nasr, Matteo Bottai, et al.
Hepatology Communications|February 7, 2018
Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up studyHannes Hagström, Patrik Nasr, Mattias Ekstedt, et al.
Hepatology (Baltimore, Md.)|August 16, 2014
Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-upMattias Ekstedt, Hannes Hagström, Patrik Nasr, et al.
European Journal of Gastroenterology & Hepatology|August 16, 2020
A personalized treatment program in persons with type 2 diabetes is associated with a reduction in liver steatosisKarl Björkström, Per Stål, Magnus Holmer, et al.
Scandinavian Journal of Gastroenterology|September 13, 2016
SAF score and mortality in NAFLD after up to 41 years of follow-upHannes Hagström, Patrik Nasr, Mattias Ekstedt, et al.
Scientific Reports|November 28, 2022
Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver diseaseMagnus Holmer, Hannes Hagström, Ping Chen, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|October 28, 2020
Variation in textural parameters of hepatic lesions during contrast medium injectionYi-Hua Zhang, Katharina Brehmer, Anders Svensson, et al.
Hepatology (Baltimore, Md.)|December 17, 2009
Decreased survival of subjects with elevated liver function tests during a 28-year follow-upCecilia Söderberg, Per Stål, Johan Askling, et al.
Frontiers in Pediatrics|June 26, 2020
Epigenetic Marks at the Ribosomal DNA Promoter in Skeletal Muscle Are Negatively Associated With Degree of Impairment in Cerebral PalsyFerdinand von Walden, Rodrigo Fernandez-Gonzalo, Jessica Pingel, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 22, 2022
Skeletal muscle morphology, satellite cells, and oxidative profile in relation to physical function and lifelong endurance training in very old menElisabeth Skoglund, Per Stål, Tommy R Lundberg, et al.
Pageof 13